Life Science News
Latest updates from the biotech and pharma world
A compounding pharmacy hits back at Eli Lilly, Novo Nordisk with antitrust lawsuit
FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory
Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035
#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash
Novo Nordisk’s weight loss pill approved by FDA
Novo Nordisk eyes a strong launch with FDA approval of obesity pill
Novo Nordisk hit with FDA warning letter over acquired Catalent factory
Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial
Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials
#Novo Nordisk#closely-watched Alzheimer#long shot#long shots#Nordisk semaglutide
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
#Novo Nordisk#watched Alzheimer#misses goal#heart health#combat neurodegeneration
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
#Therapeutic Innovations#Forecast Report#Featuring Lonza#Novo Nordisk#Market Therapeutic